FDA Quietly Bans Another Cheap Cancer Treatment: Intravenous Vitamin C

‘It would be naive to think that the FDA endeavors to protect the public’s health as its primary focus.
Indeed, that would be a conflict of interest, as it serves its master, the pharmaceutical industry.
Has the Food and Drug Administration engineered a shortage of intravenous vitamin C as part of an overall attack on natural and non-toxic approaches to healing that compete with prescription drugs?
An analysis by Natural Blaze would suggest that the answer is yes.’
Read more: FDA Quietly Bans Another Cheap Cancer Treatment: Intravenous Vitamin C